FDA Inspection 707295 — Zafar Jamil Md
The FDA completed an inspection of Zafar Jamil Md on Jan 10, 2011 in Newark, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 10, 2011
- Fiscal Year
- 2011
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Newark, NJ (United States)
Additional details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 14505 | 21 CFR 812.140(a)(3) | Investigator's subject records inadequate |
| 2974 | 21 CFR 812.110(b) | Investigator non-compliance with agreement/plan/regulations |
| 2980 | 21 CFR 812.140(a)(1) | Investigator correspondence records inadequate |
| 2982 | 21 CFR 812.140(a)(2)(ii) | Investigator records of persons receiving devices inadequate |
| 3064 | 21 CFR 812.140(a)(4) | Investigator protocol records inadequate |
| 7012 | 21 CFR 812.100 | Investigator lack of control of investigational devices |
| 7227 | 21 CFR 50.27(a) | Consent form not approved/signed/dated |